Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 2000;8(2):105–111. doi: 10.1002/(SICI)1098-0997(2000)8:2<105::AID-IDOG8>3.0.CO;2-H

Effect of imiquimod on cytokine induction in first trimester trophoblasts.

J M Manlove-Simmons 1, F M Zaher 1, M Tomai 1, B Gonik 1, D M Svinarich 1
PMCID: PMC1784669  PMID: 10805366

Abstract

OBJECTIVES: Imiquimod (IQ) is used clinically for the topical treatment of external genital warts. IQ is an immune response modifier and induces the expression of interferon-alpha and other cytokines in human Peripheral Blood Monocytes (PBMC). Trophoblasts have been previously shown to express inflammatory cytokines upon lipopolysaccharide (LPS) stimulation. The objective of this study was to evaluate the ability of IQ to induce transcription of cytokines in trophoblasts. METHODS: A transformed human first trimester trophoblast cell line, HTR-8/SVneo, was cultured in DMEM containing IQ at concentrations of 0 to 5.0 microg/ml. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) viability assays were conducted to control for any drug-induced cell death. Total RNA was isolated from trophoblasts at 0, 8 and 24 hours of culture and Reverse Transcription-Polymerase Chain Reaction (RT-PCR) was conducted using specific amplimers for the inflammatory cytokines interleukin (IL)-1alpha, IL-1beta, IL-6 and IL-8. RT-PCR of beta-actin was performed to control for equal RNA loading. RESULTS: RT-PCR was unable detect an increase in either IL-1alpha, IL-1beta, IL-6 or IL-8 mRNA in first trimester trophoblasts cultured in the presence of 0 to 5.0 microg/mL of IQ for up to 24 hours. RT-PCR confirmed equal RNA loading and MTT viability assays did not show loss of cell viability at concentrations of IQ up to 5.0 microg/ml. CONCLUSIONS: IQ, at the concentrations tested, did not induce the transcriptional expression of inflammatory cytokines in human first trimester trophoblasts. These data suggest that IQ would not induce the expression of inflammatory cytokines in placental trophoblasts.

Full Text

The Full Text of this article is available as a PDF (2.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beutner K. R., Tyring S. K., Trofatter K. F., Jr, Douglas J. M., Jr, Spruance S., Owens M. L., Fox T. L., Hougham A. J., Schmitt K. A. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Antimicrob Agents Chemother. 1998 Apr;42(4):789–794. doi: 10.1128/aac.42.4.789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Dudley D. J., Trautman M. S., Mitchell M. D. Inflammatory mediators regulate interleukin-8 production by cultured gestational tissues: evidence for a cytokine network at the chorio-decidual interface. J Clin Endocrinol Metab. 1993 Feb;76(2):404–410. doi: 10.1210/jcem.76.2.8432783. [DOI] [PubMed] [Google Scholar]
  3. Edwards L., Ferenczy A., Eron L., Baker D., Owens M. L., Fox T. L., Hougham A. J., Schmitt K. A. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus. Arch Dermatol. 1998 Jan;134(1):25–30. doi: 10.1001/archderm.134.1.25. [DOI] [PubMed] [Google Scholar]
  4. Gibson S. J., Imbertson L. M., Wagner T. L., Testerman T. L., Reiter M. J., Miller R. L., Tomai M. A. Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609. J Interferon Cytokine Res. 1995 Jun;15(6):537–545. doi: 10.1089/jir.1995.15.537. [DOI] [PubMed] [Google Scholar]
  5. Graham C. H., Hawley T. S., Hawley R. G., MacDougall J. R., Kerbel R. S., Khoo N., Lala P. K. Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res. 1993 Jun;206(2):204–211. doi: 10.1006/excr.1993.1139. [DOI] [PubMed] [Google Scholar]
  6. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16;65(1-2):55–63. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
  7. Svinarich D. M., Bitonti O. M., Araneda H., Romero R., Gonik B. Induction and postranslational expression of G-CSF and RANTES in a first trimester trophoblast cell line by lipopolysaccharide. Am J Reprod Immunol. 1996 Nov;36(5):256–259. doi: 10.1111/j.1600-0897.1996.tb00173.x. [DOI] [PubMed] [Google Scholar]
  8. Svinarich D. M., Bitonti O. M., Romero R., Gonik B. Induction and posttranslational expression of cytokines in a first-trimester trophoblast cell line by lipopolysaccharide. Am J Obstet Gynecol. 1996 Oct;175(4 Pt 1):970–973. doi: 10.1016/s0002-9378(96)80034-2. [DOI] [PubMed] [Google Scholar]
  9. Testerman T. L., Gerster J. F., Imbertson L. M., Reiter M. J., Miller R. L., Gibson S. J., Wagner T. L., Tomai M. A. Cytokine induction by the immunomodulators imiquimod and S-27609. J Leukoc Biol. 1995 Sep;58(3):365–372. doi: 10.1002/jlb.58.3.365. [DOI] [PubMed] [Google Scholar]
  10. Weeks C. E., Gibson S. J. Induction of interferon and other cytokines by imiquimod and its hydroxylated metabolite R-842 in human blood cells in vitro. J Interferon Res. 1994 Apr;14(2):81–85. doi: 10.1089/jir.1994.14.81. [DOI] [PubMed] [Google Scholar]
  11. Wegmann T. G., Guilbert L. J. Immune signalling at the maternal-fetal interface and trophoblast differentiation. Dev Comp Immunol. 1992 Nov-Dec;16(6):425–430. doi: 10.1016/0145-305x(92)90026-9. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES